Alcohol-induced depressive-like behavior is associated with cortical norepinephrine reduction

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 4, 2010, Pages 395-401

  Getachew, Bruk ^a   Hauser, Sheketha R ^a   Taylor, Robert E ^a   Tizabi, Yousef ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol; Animal model; Depression; Frontal cortex; Hippocampus; Imipramine; Monoamines; Nomifensine; Norepinephrine uptake inhibitor; WKY rats

Indexed keywords

ALCOHOL; BIOGENIC AMINE; DESIPRAMINE; DOPAMINE; IMIP; IMIPRAMINE; NOMI; NOMIFENSINE MALEATE; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FORCED CHOICE METHOD; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; LOCOMOTION; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STRAIN DIFFERENCE; TISSUE LEVEL; WISTAR KYOTO RAT; WISTAR RAT;

ANIMALS; DEPRESSION; ETHANOL; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; IMIPRAMINE; NEUROTRANSMITTER UPTAKE INHIBITORS; NOMIFENSINE; NOREPINEPHRINE; RATS; RATS, INBRED WKY; RATS, WISTAR; SEROTONIN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77956063488     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.06.011     Document Type: Article

References (54)

1. Baldessarini Drug therapy for depression and anxiety disorders. Goodman and Gillman's the pharmacologic basis of therapeutics 2006, 429-559. McGraw-Hill, New York. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
2. Ballenger J., Goodwin F., Major L., Brown G. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979, 36:224-227.
3. Bremner J.D., Vythilingam M., Vermetten E., Nazeer A., Adil J., Khan S., et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002, 51:273-279.
4. Brown S.A., Schuckit M.A. Changes in depression among abstinent alcoholics. J Stud Alcohol 1988, 49:412-417.
5. Caldecott-Hazard S., Morgan D.G., DeLeon-Jones F., Overstreet D.H., Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 1991, 9:251-301.
6. Clausius N., Born C., Grunze H. The relevance of dopamine agonists in the treatment of depression. Neuropsychiatry 2009, 23:15-25.
7. Dackis C.A., Stuckey R.F., Gold M.S., Pottash A.C. Dexamethasone suppression test testing of depressed alcoholics. Alcohol Clin Exp Res 1986, 10:59-60.
8. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
9. Dixit A.D., Crum R.M. Prospective study of depression and the risk of heavy alcohol use in women. Am J Psychiatry 2000, 157:751-758.
10. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Lett Nat 1997, 386:824-827.
11. Getachew B., Hauser S.R., Taylor R.E., Tizabi Y. Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains. Pharmacol Biochem Behav 2008, 91:97-103.
12. Goldstein B.I., Shamseddeen W., Spirito A., Emslie G., Clarke G., Wagner K.D., et al. Substance use and the treatment of resistant depression in adolescents. J Am Acad Child Adolesc Psychiatry 2010, [Epub ahead of print].
13. Griebel G., Moreau J.-L., Jenck F., Misslin R., Martin J.R. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 1994, 113:463.
14. Heinz A., Dufeu P., Kuhn S., Dettling M., Gräf K., Kürten I., et al. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 1996, 53:1123-1128.
15. Hodgins D.C., el-Guebaly N., Armstrong S. Prospective and retrospective reports of mood states before relapse to substance use. J Consult Clin Psychol 1995, 63:400-407.
16. Howland R.H., Rush A.J., Wisniewski S.R., Trivedi M.H., Warden D., Fava M., et al. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend 2009, 99:248-260.
17. Jiao X., Pare W.P., Tejani-Butt S.M. Antidepressant drug induced alteration to central dopamine transporter sites in the Wistar Kyoto rat strain. Prog Neuro-Psychopharmacol Biol Psychiatry 2006, 30:30-41.
18. Johanson C.-E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev 1989, 41:3-52.
19. Kessler R.C., Davis C.G., Kendler K.S. Childhood adversity and adult psychiatric disorder in the U.S. National Co-morbidity Survey. Psychol Med 1997, 27:1101-1119.
20. Kliethermes C.L., Cronise K., Crabbe J.C. Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcohol Clin Exp Res 2004, 28:1012-1019.
21. Lahmame A., del Arco C., Pazos A., Yritia M., Armario A. Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?. Eur J Pharmacol 1997, 337:115-123.
22. Laine T.P., Ahonen A., Torniainen P., Heikkila J., Pyhtinen J., Rasanen P., et al. Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry 1999, 4:189-191.
23. Lee S., Schmidt D., Tilders F., Cole M., Smith A., Rivier C. Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals. Alcohol Clin Exp Res 2000, 24:110-112.
24. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
25. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8:523-532.
26. Martijena I.D., Bustos S.G., Bertotto M.E., Molina V.A. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats. Eur Neuropsychopharmacol 2005, 15:119-130.
27. Mattila M.J. Alcohol and drug interactions. Ann Med 1990, 22:363-369.
28. Mayberg H.S. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994, 6:428-442.
29. Merikangas K.R., Gelernter C.S. Comorbidity for alcoholism and depression. Psychiatry Clin North Am 1990, 13:613-632.
30. Nurnberger J.I., Berrettini W. Psychiatric genetics 1998, Chapman & Hall, London.
31. Overstreet D.H., Rezvani A.H., Janowsky D.S. Maudsley reactive and nonreactive rats differ only in some tasks reflecting emotionality. Physiol Behav 1992, 52:149-152.
32. Overstreet D.H., Friedman E., Mathe A.A., Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005, 29:739-759.
33. Overstreet D.H., Cui C.L., Ma Y.Y., Guo C.Y., Han J.S., Lukas S.E., et al. Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism. Neurochem Res 2008, 33:2166-2170.
34. Owens M.J., Morgan W.N., Plott S.J., Nemeroff C.B. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997, 283:1305-1322.
35. Paré W.P., Kluczynski J. Negative affect and voluntary alcohol consumption in Wistar-Kyoto (WKY) and Sprague-Dawley rats. Physiol Behav 1999, 67:219-225.
36. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
37. Rajkowska G. Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?. Prog Brain Res 2000, 126:397-412.
38. Ratsma J.E., Van Der Stelt O., Gunning W.B. Neurochemical markers of alcoholism vulnerability in humans. Alcohol Alcohol 2002, 37:522-533.
39. Rezvani A.H., Parsian A., Overstreet D.H. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr Genet 2002, 12:1-16.
40. Rezvani A.H., Overstreet D.H., Cleves M., Parsian A. Further genetic characterization of the Fawn-Hooded (FH/Wjd) rat, an animal model of co-morbid depression and alcoholism. Psychiatr Genet 2007, 17:77-83.
41. Rodgers B., Korten A.E., Jorm A.F., Jacomb P.A., Christensen H., Henderson A.S. No-linear relationships in associations of depression and anxiety with alcohol use. Psychol Med 2000, 30:421-432.
42. Rozas I. Improving antidepressant drugs: update on recently patented compounds. Expert Opin Ther Pat 2009, 19:827-845.
43. Salvadori C., Ward C., Defrance R., Hopkins R. The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans-influence of alcohol co-administration. Fundam Clin Pharmacol 1990, 4:115-125.
44. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007, 18:391-418.
45. Schuckit M.A., Tipp J.E., Bergman M., Reich W., Hesselbrock V.M., Smith T.L. Comparison of induced and independent major depressive disorders in 2, 945 alcoholics. Am J Psychol 1997, 154:948-957.
46. Schulteis G., Markou A., Cole M., Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci 1995, 92:5880-5884.
47. Sheline Y.I., Wang P., Gado M., Csernansky J., Vannier M. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996, 93:3908-3913.
48. Spak L., Spak A., Allebeck P. Alcoholism and depression in a Swedish female population: co-morbidity and risk factors. Acta Psychiatr Scand 2000, 102:44-51.
49. Sullivan R.M., Brake W.G. What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function. Behav Brain Res 2003, 146:43-55.
50. Tejani-Butt S., Kluczynski J., Pare W.P. Strain-dependent modification of behavior following antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:7-14.
51. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark E., Janowsky D.S., Kling M.A. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 1999, 142:193-199.
52. Tizabi Y., Getachew B., Davila-Garcia M., Taylor R.E. Alcohol preference: association with reduced striatal nicotinic receptors. Alcohol Alcohol 2001, 36:318-322.
53. Tupala E., Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1221-1247.
54. Willner P. The mesolimbic DA system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997, 12:7-14.